Ambit Health Ventures

Encapsulate is a biotechnology company focused on developing automated tumor-on-a-chip systems that facilitate personalized cancer treatment. The company's innovative technology allows for the growth of patients' cancer cells outside the body, creating micro tumors that can be preserved and utilized to assess the efficacy of various chemotherapy and biotherapeutic drugs. By screening the response profile of cancer patients to these treatments, Encapsulate aims to enable oncologists to tailor effective treatment regimens, improving outcomes in cancer care.

Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Smartlens is a clinical-stage medical technology company focused on treating and diagnosing Glaucoma, a leading cause of irreversible blindness worldwide. Its flagship product, miLens, is an innovative eye pressure monitoring contact lens designed to improve early diagnosis, personalized treatment, and disease monitoring. This non-invasive, convenient solution aims to reduce the prevalence of glaucoma-related blindness, lower treatment costs, and alleviate the burden on lives and economies.

Founded in 2019, SOAP Health improves clinical decision-making by capturing and analyzing patient data before appointments. Its platform offers augmented intelligence for physicians, graphical risk representation, and actionable insights to enhance patient care and doctor productivity.

Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Smartlens is a clinical-stage medical technology company focused on treating and diagnosing Glaucoma, a leading cause of irreversible blindness worldwide. Its flagship product, miLens, is an innovative eye pressure monitoring contact lens designed to improve early diagnosis, personalized treatment, and disease monitoring. This non-invasive, convenient solution aims to reduce the prevalence of glaucoma-related blindness, lower treatment costs, and alleviate the burden on lives and economies.

Founded in 2018 and based in Redwood City, California, Bone Health Technologies designs and manufactures OsteoBoost, a wearable medical device that uses whole-body vibration technology to provide weight-bearing exercise and mechanical stimulation to the hips and spine. Clinically proven to slow bone density loss in postmenopausal women with osteopenia, OsteoBoost offers a convenient, non-pharmacological, pain-free treatment option for nearly 64 million Americans at risk of osteoporotic fractures.